Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
Open Access
- 3 June 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-19
Abstract
Regulatory B cells (Breg) are a heterogenous population with immune-modulating functions. The rarity of human IL-10+ Breg makes translational studies difficult. Here we report ex vivo expansion of human B cells with in vivo regulatory function (expBreg). CD154-stimulation of human CD19+ B cells drives >900-fold expansion of IL-10+ B cells that is maintained in culture for 14 days. Whilst expBreg-mediated suppressive function is partially dependent on IL-10 expression, CRISPR-mediated gene deletions demonstrate predominant roles for TIM-1 and CD154. TIM-1 regulates STAT3 signalling and modulates downstream suppressive function. In a clinically relevant humanised mouse model of skin transplantation, expBreg prolongs human allograft survival. Meanwhile, CD19+CD73-CD25+CD71+TIM-1+CD154+ Breg cells are enriched in the peripheral blood of human donors with cutaneous squamous cell carcinoma (SCC). TIM-1+ and pSTAT3+ B cells are also identified in B cell clusters within histological sections of human cutaneous SCC tumours. Our findings thus provide insights on Breg homoeostasis and present possible targets for Breg-related therapies.Keywords
Funding Information
- Wellcome Trust (HJRWQJ00)
- Royal College of Surgeons of England (HJMBWWG/A)
- DH | National Institute for Health Research
This publication has 57 references indexed in Scilit:
- The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challengesBriefings in Functional Genomics, 2013
- B Cells Promote Tumor Progression via STAT3 Regulated-AngiogenesisPLOS ONE, 2013
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactionsNature, 2012
- Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant miceProceedings of the National Academy of Sciences, 2012
- Ex Vivo–Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse ModelTransplantation, 2010
- Identification of a B cell signature associated with renal transplant tolerance in humansJournal of Clinical Investigation, 2010
- Development of a cross-platform biomarker signature to detect renal transplant tolerance in humansJournal of Clinical Investigation, 2010
- In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cellsNature Medicine, 2010
- FcRγ Activation Regulates Inflammation-Associated Squamous CarcinogenesisCancer Cell, 2010
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008